Keryx Biopharma (KERX) Posts Narrower than Expected Q2 Loss of 2c/Share
Tweet
Share
E-mailGet Alerts KERX Hot Sheet
Price: $3.36 --0%
Financial Fact:
Interest and other income, net: 150K
Today's EPS Names:
CP, RUSHA, SEIC, More
Financial Fact:
Interest and other income, net: 150K
Today's EPS Names:
CP, RUSHA, SEIC, More
Join SI Premium – FREE
Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX) reported Q2 EPS of ($0.02), $0.07 better than the analyst estimate of ($0.09).
For earnings history and earnings-related data on Keryx Biopharmaceuticals, Inc. (KERX) click here.
For earnings history and earnings-related data on Keryx Biopharmaceuticals, Inc. (KERX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Amphenol (APH) Tops Q1 EPS by 7c, offers guidance
- JPMorgan says S&P 500 tactical bounce 'poised to continue'
- Pervasip Corp. (PVSP) Reports Q1 EPS of $0.00
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
